TOBINintel · Condition

Hypothyroidism & Hashimoto's Thyroiditis

Primary hypothyroidism is most often autoimmune (Hashimoto's thyroiditis). It is diagnosed by TSH with free T4, and anti-TPO antibodies identify the autoimmune form. Iodine status, selenium, iron, pregnancy and certain medications all modify thyroid function.

Key points

Infection triggers for thyroid autoimmunity remain hypotheses; no antimicrobial treatment is indicated for Hashimoto's.
Test to discuss: TSH with free T4
Test to discuss: Anti-TPO antibodies
Test to discuss: Lipid panel
Test to discuss: Ferritin and B12 (common co-deficiencies)
Test to discuss: Pregnancy status — targets differ in pregnancy
Adequate, not excessive, iodine
Avoid unnecessary high-dose biotin before thyroid tests (assay interference)
Separate levothyroxine from calcium, iron and coffee by 4 hours / 30–60 minutes

Root-cause chain

Thyroid autoimmunity (anti-TPO) → Progressive loss of thyroid hormone outputA

I · Established causal · Lymphocytic infiltration destroys thyroid follicles; anti-TPO positivity predicts progression to overt hypothyroidism (Whickham survey).

Iodine deficiency or excess → Altered thyroid hormone synthesisA

N · Established causal · Iodine is required for T4/T3 synthesis; both deficiency and excess can trigger hypothyroidism in susceptible people.

Perchlorate and other thyroid-active chemicals → Reduced iodide uptakeC

T · Exposure signal · Perchlorate competitively inhibits the sodium-iodide symporter; NHANES links urinary perchlorate with TSH in low-iodine women. Detection is not proof of effect.

Hypothyroidism → Raised LDL and weight gainA

B · Established causal · Reduced LDL-receptor expression and lower basal metabolic rate; corrected by levothyroxine.

Protocols by lane

Evidence grade + regulatory status

Conventional: Levothyroxine replacement titrated to TSHA

Standard of care for overt hypothyroidism (ATA guideline).

Status: FDA-approved · Cautions: Start low in older adults and heart disease; over-replacement raises atrial fibrillation and bone-loss risk.

Functional: Evaluate iron, B12 and vitamin D when symptoms persist on therapyC

Co-existing deficiencies are common and treatable.

Status: Lifestyle · Cautions: Treat measured deficiencies only.

Integrative: Regular exercise and sleep regularityB

Improves fatigue and cardiometabolic risk; does not replace hormone therapy.

Status: Lifestyle · Cautions: Adapt to fatigue level.

Orthomolecular: Selenium 200 µg/day in anti-TPO-positive patientsC

Trials show lower anti-TPO titers; effect on clinical outcomes is uncertain.

Status: Supplement · Cautions: Upper limit 400 µg/day; excess linked to type 2 diabetes risk.

Traditional: Whole-food dietary pattern with iodized salt where iodine-poorB

Supports adequate iodine and micronutrients.

Status: Lifestyle · Cautions: Avoid kelp/iodine megadoses.

Energy / Physical: Low-level laser therapy to the thyroidE

Small trials only; not a substitute for levothyroxine.

Status: Investigational · Cautions: Must not be presented as a treatment for hypothyroidism.

Monitoring

TSH 6–8 weeks after any dose change
TSH every 6–12 months once stable
Symptom and weight trend
TOBIN score change over time

Go deeper

Full condition page →Library: formulas & sources →All TOBINintel entries

iDetection of an exposure does not establish that it caused a disease. This platform separates exposure, association, plausible mechanism, clinical evidence and demonstrated causation.